Glenmark’s Teneligliptin Launch To Shake Up Indian DPP-4 Sector?

Glenmark has launched teneligliptin, a cut-price generic version of Mitsubishi Tanabe Pharma's dipeptidyl peptidase-4 (DPP-4) inhibitor Tenelia, in India via a dual brand approach and ahead of the original product, in a move that could spark more pricing action in the diabetes sector.